Literature DB >> 3545275

Lymphocyte subsets in tumour of patients with undifferentiated nasopharyngeal carcinoma: presence of lymphocytes with the phenotype of activated T cells.

P Herait, G Ganem, M Lipinski, C Carlu, C Micheau, G Schwaab, G De-The, T Tursz.   

Abstract

We have analyzed lymphocytes infiltrating nasopharyngeal carcinomas, using a combination of immunoperoxidase staining of frozen and paraffin-embedded sections, and immunofluorescence on lymphocyte suspensions recovered from teased tumours. A panel of monoclonal antibodies was used to define lymphocytic subsets on frozen sections of 14 different tumours. The vast majority of peri- and intra-tumoral lymphocytes were stained by OKT3 antibody. In 8 sections, T4 positive cells were largely predominant, while T8 positive cells were the majority in three sections. Twenty-nine paraffin-embedded sections from other NPC patients stained with HNK-1 antibody showed a variable percentage of positive cells reaching 6 to 15% in nine patients. Most HNK-1 positive cells had the morphology of large granular lymphocytes typical of natural killer cells. Double staining experiments on lymphocytes isolated from 7 tumours revealed a constant presence of T3 positive, HLA-DR positive lymphocytes (from 6 to 29% of mononuclear cells), and of lymphocytes coexpressing the T3 and the Tac (IL-2 receptor) antigens (from 5 to 12% of mononuclear cells). Lymphocytes with a phenotype of activated T-cells are thus constantly found in NPC tumours.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3545275      PMCID: PMC2002096          DOI: 10.1038/bjc.1987.28

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  23 in total

1.  Antibody-dependent cellular cytotoxicity against Epstein-Barr virus-associated antigens in African patients with nasopharyngeal carcinoma.

Authors:  G R Pearson; B Johansson; G Klein
Journal:  Int J Cancer       Date:  1978-08-15       Impact factor: 7.396

2.  Nasopharyngeal carcinoma. IX. Antibodies to EBNA and correlation with response to other ebv antigens in chinese patients.

Authors:  G de-Thé; J H Ho; D V Ablashi; N E Day; A J Macario; M C Martin-Berthelon; G Pearson; R Sohier
Journal:  Int J Cancer       Date:  1975-11-15       Impact factor: 7.396

3.  Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma.

Authors:  G Henle; W Henle
Journal:  Int J Cancer       Date:  1976-01-15       Impact factor: 7.396

4.  IL 2 receptor induction on human T lymphocytes: role for IL 2 and monocytes.

Authors:  H Wakasugi; J Bertoglio; T Tursz; D Fradelizi
Journal:  J Immunol       Date:  1985-07       Impact factor: 5.422

Review 5.  Morphological and functional characterization of isolated effector cells responsible for human natural killer activity to fetal fibroblasts and to cultured cell line targets.

Authors:  E Saksela; T Timonen; A Ranki; P Häyry
Journal:  Immunol Rev       Date:  1979       Impact factor: 12.988

6.  Antibodies to Epstein-Barr virus-related antigens in nasopharyngeal carcinoma. Comparison of active cases with long-term survivors.

Authors:  W Henle; H C Ho; G Henle; H C Kwan
Journal:  J Natl Cancer Inst       Date:  1973-08       Impact factor: 13.506

7.  EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx.

Authors:  H zur Hausen; H Schulte-Holthausen; G Klein; W Henle; G Henle; P Clifford; L Santesson
Journal:  Nature       Date:  1970-12-12       Impact factor: 49.962

8.  Histopathology of nasopharyngeal carcinoma: correlations with epidemiology, survival rates and other biological characteristics.

Authors:  K Shanmugaratnam; S H Chan; G de-Thé; J E Goh; T H Khor; M J Simons; C Y Tye
Journal:  Cancer       Date:  1979-09       Impact factor: 6.860

9.  Ia determinants on human T-cell subsets defined by monoclonal antibody. Activation stimuli required for expression.

Authors:  E L Reinherz; P C Kung; J M Pesando; J Ritz; G Goldstein; S F Schlossman
Journal:  J Exp Med       Date:  1979-12-01       Impact factor: 14.307

10.  Absence of allogeneic restriction in human T-cell-mediated cytotoxicity to Epstein-Barr virus-infected target cells. Demonstration of an HLA-linked control at the effector level.

Authors:  M Lipinski; W H Fridman; T Tursz; C Vincent; D Pious; M Fellous
Journal:  J Exp Med       Date:  1979-12-01       Impact factor: 14.307

View more
  10 in total

Review 1.  Lessons from rare tumors: hepatic lymphoepithelioma-like carcinomas.

Authors:  Antonio Solinas; Diego F Calvisi
Journal:  World J Gastroenterol       Date:  2015-03-28       Impact factor: 5.742

2.  Epstein-Barr virus-containing epithelial cells from nasopharyngeal carcinoma produce interleukin 1 alpha.

Authors:  P Busson; K Braham; G Ganem; F Thomas; D Grausz; M Lipinski; H Wakasugi; T Tursz
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

3.  Expression of immune regulatory molecules in Epstein-Barr virus-associated nasopharyngeal carcinomas with prominent lymphoid stroma. Evidence for a functional interaction between epithelial tumor cells and infiltrating lymphoid cells.

Authors:  A Agathanggelou; G Niedobitek; R Chen; J Nicholls; W Yin; L S Young
Journal:  Am J Pathol       Date:  1995-10       Impact factor: 4.307

4.  Epstein-Barr virus (EBV)-containing nasopharyngeal carcinoma cells express the B-cell activation antigen blast2/CD23 and low levels of the EBV receptor CR2.

Authors:  M Billaud; P Busson; D Huang; N Mueller-Lantzch; G Rousselet; O Pavlish; H Wakasugi; J M Seigneurin; T Tursz; G M Lenoir
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

5.  Epstein-Barr virus lytic transactivator Zta enhances chemotactic activity through induction of interleukin-8 in nasopharyngeal carcinoma cells.

Authors:  Meichi Hsu; Shih-Yi Wu; Shih-Shin Chang; Ih-Jen Su; Ching-Hwa Tsai; Siao-Jing Lai; Ai-Li Shiau; Kenzo Takada; Yao Chang
Journal:  J Virol       Date:  2008-01-30       Impact factor: 5.103

6.  Therapeutic targeting of regulatory T cells enhances tumor-specific CD8+ T cell responses in Epstein-Barr virus associated nasopharyngeal carcinoma.

Authors:  Mark Fogg; John R Murphy; Jochen Lorch; Marshall Posner; Fred Wang
Journal:  Virology       Date:  2013-04-17       Impact factor: 3.616

Review 7.  Control of the inflammatory response mechanisms mediated by natural and induced regulatory T-cells in HCV-, HTLV-1-, and EBV-associated cancers.

Authors:  Laurissa Ouaguia; Dhafer Mrizak; Sarah Renaud; Olivier Moralès; Nadira Delhem
Journal:  Mediators Inflamm       Date:  2014-11-30       Impact factor: 4.711

Review 8.  Nasopharyngeal Carcinoma and Its Microenvironment: Past, Current, and Future Perspectives.

Authors:  Zhi Yi Su; Pui Yan Siak; Chee-Onn Leong; Shiau-Chuen Cheah
Journal:  Front Oncol       Date:  2022-03-02       Impact factor: 6.244

9.  Site-specific localization of Epstein-Barr virus in pharyngeal carcinomas.

Authors:  S Kojya; T Itokazu; Y Noda; M Ezaki; Y Tomita; M Ohsawa; K Aozasa
Journal:  Jpn J Cancer Res       Date:  1998-05

10.  Infiltrating lymphocytes and accessory cells in nasopharyngeal carcinoma.

Authors:  Y S Zong; C Q Zhang; F Zhang; J B Ruan; M Y Chen; K T Feng; Z F Yu
Journal:  Jpn J Cancer Res       Date:  1993-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.